Research
Little-known protein offers a potential target for treating Chagas disease
The Brief
- Researchers at the University of São Paulo (USP) and collaborators identified a protein as a promising target for new Chagas disease treatments.
- In laboratory tests, the team interrupted the infection cycle of the Trypanosoma cruzi parasite by targeting this protein.
- The findings are from laboratory work; the source excerpt does not report clinical testing in humans.
Why it matters
Chagas disease is caused by Trypanosoma cruzi, and current treatments are limited, so identifying a new drug target could inform future therapy development. The results so far come from lab experiments only.
Who’s affected
- researchers working on parasitic and neglected tropical diseases
- people affected by Chagas disease in Latin America
- #chagas disease
- #trypanosoma cruzi
- #parasitology
- #drug target
- #neglected diseases
In Brazil, researchers at the University of São Paulo (USP) and their collaborators have identified a promising target for developing new Chagas disease treatments. In laboratory tests, the group succeeded in interrupting the infection cycle of the Trypanosoma cruzi parasite by…
Timeline
Medical Xpress reported the USP-led identification of the protein as a potential Chagas treatment target
Medical Xpress - latest medical and health news stories
Little-known protein offers a potential target for treating Chagas disease